Molecular Templates, Inc. (MTEM): Price and Financial Metrics
MTEM Price/Volume Stats
Current price | $0.39 | 52-week high | $5.37 |
Prev. close | $0.40 | 52-week low | $0.30 |
Day low | $0.38 | Volume | 831,300 |
Day high | $0.42 | Avg. volume | 2,825,190 |
50-day MA | $0.87 | Dividend yield | N/A |
200-day MA | $1.62 | Market Cap | 2.55M |
MTEM Stock Price Chart Interactive Chart >
Molecular Templates, Inc. (MTEM) Company Bio
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is based in Austin, Texas.
MTEM Price Returns
1-mo | -44.83% |
3-mo | -74.68% |
6-mo | -68.80% |
1-year | -91.94% |
3-year | -99.38% |
5-year | -99.74% |
YTD | -89.54% |
2023 | -24.19% |
2022 | -91.63% |
2021 | -58.25% |
2020 | -32.86% |
2019 | 246.16% |
Continue Researching MTEM
Want to see what other sources are saying about Molecular Templates Inc's financials and stock price? Try the links below:Molecular Templates Inc (MTEM) Stock Price | Nasdaq
Molecular Templates Inc (MTEM) Stock Quote, History and News - Yahoo Finance
Molecular Templates Inc (MTEM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...